Cargando…

The effects of MYC on tumor immunity and immunotherapy

The oncogene MYC is dysregulated in a host of human cancers, and as an important point of convergence in multitudinous oncogenic signaling pathways, it plays a crucial role in tumor immune regulation in the tumor immune microenvironment (TIME). Specifically, MYC promotes the expression of immunosupp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiajin, Dong, Tingyu, Wu, Zhen, Zhu, Dacheng, Gu, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039951/ https://www.ncbi.nlm.nih.gov/pubmed/36966168 http://dx.doi.org/10.1038/s41420-023-01403-3

Ejemplares similares

Impact of MYC on Anti-Tumor Immune Responses in Aggressive B Cell Non-Hodgkin Lymphomas: Consequences for Cancer Immunotherapy
por: de Jonge, A. Vera, et al.
Publicado: (2020)

Role of the tumor immune microenvironment in tumor immunotherapy
por: Zhou, Changsheng, et al.
Publicado: (2022)

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
por: Li, Zhilin, et al.
Publicado: (2022)

NK cell-based tumor immunotherapy
por: Zhang, Hao, et al.
Publicado: (2023)

Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors
por: Xu, Liangliang, et al.
Publicado: (2022)

Targeted mechanical forces enhance the effects of tumor immunotherapy by regulating immune cells in the tumor microenvironment
por: Zhu, Pengfei, et al.
Publicado: (2023)

Next frontier in tumor immunotherapy: macrophage-mediated immune evasion
por: Qiu, Yingqi, et al.
Publicado: (2021)

Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

MYC in Regulating Immunity: Metabolism and Beyond
por: Gnanaprakasam, J.N. Rashida, et al.
Publicado: (2017)

MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination
por: Wu, Xiaofang, et al.
Publicado: (2021)

Tumor microenvironment: becoming sick of Myc
por: Whitfield, Jonathan R., et al.
Publicado: (2011)

Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy
por: He, Yunbo, et al.
Publicado: (2022)

The relationship between autophagy and the immune system and its applications for tumor immunotherapy
por: Jiang, Guan-Min, et al.
Publicado: (2019)

Tumor immune response and immunotherapy in gastric cancer
por: Kwak, Yoonjin, et al.
Publicado: (2020)

Modelling the tumor immune microenvironment for precision immunotherapy
por: Mackenzie, Nathan J, et al.
Publicado: (2022)

Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)
por: Yang, Siqi, et al.
Publicado: (2023)

Type I interferon-mediated tumor immunity and its role in immunotherapy
por: Yu, Renren, et al.
Publicado: (2022)

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
por: Payne, Kyle K., et al.
Publicado: (2012)

Tumor-Derived Extracellular Vesicles: Their Role in Immune Cells and Immunotherapy
por: Li, Qi, et al.
Publicado: (2021)

VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy
por: Huang, Xing, et al.
Publicado: (2020)

Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical Tumors
por: Lainé, Alexandra, et al.
Publicado: (2023)

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
por: Devaud, Christel, et al.
Publicado: (2013)

Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy
por: Coleman, Michael F., et al.
Publicado: (2020)

Tissue-resident memory T cells in tumor immunity and immunotherapy
por: Okła, Karolina, et al.
Publicado: (2021)

A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors
por: Li, Zhen, et al.
Publicado: (2013)

Immunotherapy: Reshape the Tumor Immune Microenvironment
por: LV, Bingzhe, et al.
Publicado: (2022)

Myc proteins in brain tumor development and maintenance
por: Swartling, Fredrik J.
Publicado: (2012)

The Immune Response to Tumors as a Tool toward Immunotherapy
por: Pandolfi, F., et al.
Publicado: (2011)

Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
por: Schaaf, Marco B., et al.
Publicado: (2018)

The roles of ERIANIN in tumor and innate immunity and its’ perspectives in immunotherapy
por: Yang, Zhen, et al.
Publicado: (2023)

Small-Molecule Targets in Tumor Immunotherapy
por: Zhu, Hui-Fang, et al.
Publicado: (2018)

Modeling and Targeting MYC Genes in Childhood Brain Tumors
por: Hutter, Sonja, et al.
Publicado: (2017)

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

The Cellular Tumor Immune Microenvironment of Childhood Solid Cancers: Informing More Effective Immunotherapies
por: Holterhus, Malcolm, et al.
Publicado: (2022)

T cell effects and mechanisms in immunotherapy of head and neck tumors
por: Xiang, Yizhen, et al.
Publicado: (2023)

Immune Landscape in Tumor Microenvironment: Implications for Biomarker Development and Immunotherapy
por: Pérez-Romero, Karim, et al.
Publicado: (2020)

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
por: Arora, Sanjeevani, et al.
Publicado: (2019)

Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy
por: Najem, Hinda, et al.
Publicado: (2021)

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
por: Naimi, Adel, et al.
Publicado: (2022)

Engineering approaches for studying immune-tumor cell interactions and immunotherapy
por: Shelton, Sarah E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u454i0i5j2g88i9gv1b7saiq3a